ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$66.48
arrow_downward
-1.86%(-1.26) 1D
$67.00
arrow_upward
+0.78% (+0.52)bedtimeAfter hours
Closed: Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARWR...
Open
$67.83
High
$68.05
Low
$66.36
Mkt. cap
9.39B
Avg. vol.
1.52M
Volume
4.02M
52-wk high
$95.49
52-wk low
$30.25
EPS
-$2.24
Beta
1.28
Shares outstanding
141.25M
No. of employees
711
Open
$67.83
High
$68.05
Low
$66.36
Mkt. cap
9.39B
Avg. vol.
1.52M
Volume
4.02M
52-wk high
$95.49
52-wk low
$30.25
EPS
-$2.24
Beta
1.28
Shares outstanding
141.25M
No. of employees
711
News stories
From web sources and news partners
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitearrowheadpharma.com